Tumor-LN-oC updates- November 25, 2024- Online
Author
Camila Betterelli Giuliano, PhD
Publication Date
Keywords
Tumor-LN-oC
drug testing
Organ-on-a-chip Platform
metastasis diagnosis
project meeting
Your microfluidic SME partner for Horizon Europe
We take care of microfluidic engineering, work on valorization and optimize the proposal with you
On November 25, we had an incredibly productive and insightful online meeting to discuss Tumor-LN-oC updates, progress, challenges, and the next steps as we approach the final year of our project!
With just one year to go, we are proud to have achieved proof of concept, and we are excited to announce that the integration of all developed technological components of the final platform at ICCS – NTUA in Athens is scheduled for early 2025. We’ve made significant progress and are confident that any potential challenges have already been addressed.
We’re now ready and looking forward to the integration and validation of the Tumor-LN-oC organ-on-chip platform for metastasis diagnosis and drug testing during the last year of the project!
A big thank you to all our partners for your active participation in both the meeting and the project as a whole (though not everyone could be captured in the picture below!)
ICCS – NTUA / AMIRES / ASPHALION / RayFos Ltd. / Eindhoven University of Technology / Åbo Akademi University / Technische Universität Wien / Microfluidics Innovation Center / Alpes Lasers / Biomedical Research Foundation of the Academy of Athens / PhosPrint P.C.
